Ursodeoxycholic Acid Market Applications, SWOT Analysis, and Growth Trends Report
Global Ursodeoxycholic Acid Market is anticipated to grow at a CAGR of 7% in the forecast period owing to the developments occurring worldwide and changing demand from patients.
(firmenpresse) - Global Ursodeoxycholic Acid Market is anticipated to grow at a CAGR of 7% in the forecast period owing to the developments occurring worldwide and changing demand from patients. Ursodeoxycholic acid is a steroid bile acid used for treating liver disorder. It naturally occurs in form of bile acid and is used to liquefy gallstones, which are rich in cholesterol. It also helps in improving the bile flow in primary biliary cirrhosis.
Ursodeoxycholic acid dissolves the cholesterol rich gallstones that accumulate due to cholesterol deposit. The acid helps prevent gallstone formation in patients
Ursodeoxycholic acid also treats liver related symptom of cystic fibrosis, which is mostly present in children of 6-18 years of age. However, few symptoms may hamper the growth of ursodeoxycholic acid market. These symptoms comprise headache, diarrhea, hair loss, indigestion, vomiting or nausea, backache, unusual bleeding or bruising, cloudy and bloody urine, fever and cough, tarry or black stools, painful and/or frequent urination, swelling of lips, eyelids, tongue and face.
The market is categorized on the basis of product type, applications, and geography. On the basis of product type, market is divided into synthetic ursodeoxycholic acid and extraction ursodeoxycholic acid. Based on applications, market is divided into pharmacy and health products.
Geographically, market is segmented as North America, Europe, Asia Pacific, and RoW (Rest of the World). Asia Pacific is expected to hold the largest share of ursodeoxycholic acid market owing to the rise in liver diseases and rising elderly population in the region.
The key players in ursodeoxycholic acid market include ICE, Mitsubishi Tanabe Pharma, Arcelor Chemicals, Daewoong Chemical, Erregierre, Dipharma Francis, PharmaZell GmbH, Suzhou Tianlu, Grindeks, Abil Chempharma, Biotavia Labs, and Zhangshanbelling.
Themen in dieser Pressemitteilung:
ursodeoxycholic-acid-market
pharmaceuticals
ursodeoxycholic-acid
ursodeoxycholic-acid-industry
pharmaceuticals-market
pharmaceuticals-industry
Unternehmensinformation / Kurzprofil:
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive marketplace that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
"Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: +1-408-610-2300
Toll Free: +1-866-831-4085
Email: sales(at)millioninsights.com"
Datum: 19.09.2019 - 02:51 Uhr
Sprache: Deutsch
News-ID 1552341
Anzahl Zeichen: 11049
contact information:
Contact person: Tom Clark
Town:
Felton
Phone: 14086102300
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 19.09.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 336 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ursodeoxycholic Acid Market Applications, SWOT Analysis, and Growth Trends Report
"
steht unter der journalistisch-redaktionellen Verantwortung von
Million Insights (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
